Thai Prophylactic HIV Vaccine Phase I Study
Stopped Vaccines safe but not immunogenic in 8 participants; trial closed to further recruitment by the protocol steering committee \& DSMB.
Conditions
Interventions
- BIOLOGICAL: pHIS-HIV-AE (DNA vaccine) prime and rFPV-HIV-AE (recombinant fowlpox virus boost) vaccine
Sponsor
Kirby Institute
Collaborators